Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis
JAMA Psychiatry  (IF21.596),  Pub Date : 2022-02-01, DOI: 10.1001/jamapsychiatry.2021.3710
Rakshathi Basavaraju, Jia Guo, Scott A. Small, Jeffrey A. Lieberman, Ragy R. Girgis, Frank A. Provenzano

This study examines the association between increased hippocampal glutamate and higher total positive symptom severity in converters to psychosis.